AI Quantitative Coronary Angiography Versus Optical Coherent Tomography

See also
Status	Clinical Trial	Phase
Completed	`NCT03401203` - Debulking With Rotational Atherectomy Versus Balloon Angioplasty In Patients With In-stent Restenosis	N/A
Completed	`NCT00427232` - Endothelin-Receptor Blockade in Coronary Heart Disease	Phase 1
Recruiting	`NCT04414176` - Iran- Premature Coronary Artery Disease
Active, not recruiting	`NCT03394079` - Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT03401203 - Debulking With Rotational Atherectomy Versus Balloon Angioplasty In Patients With In-stent Restenosis

N/A

Completed

NCT00427232 - Endothelin-Receptor Blockade in Coronary Heart Disease

Phase 1

Recruiting

NCT04414176 - Iran- Premature Coronary Artery Disease

Active, not recruiting

NCT03394079 - Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05388357
Study type	Interventional
Source	Asan Medical Center
Contact
Status	Active, not recruiting
Phase	N/A
Start date	October 4, 2022
Completion date	June 30, 2025

AI Quantitative Coronary Angiography Versus Optical Coherent Tomography Guidance for Coronary Stent Implantation — FLASH

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms